Nina Bhatia, MD
Urogynecology and Reconstructive Pelvic Surgery · Manalapan, NJNPI 1295960706
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.2%), education and other — rather than concentrated in one kind of arrangement. Coloplast accounts for 70.3% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $27,462 and has fallen 97.1% since, to $808 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $187.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$54K
- Intuitive Surgical$13K
- Axonics, Inc.$4K
- Caldera Medical, Inc$2K
- Medtronic$932
- Seaspine Orthopedics Corporation$807
- plus $2K from 18 others
What the payments were for
- Consulting fees$31,65541%
- Speaking & faculty fees$2410%
- Travel & lodging$9,39912%
- Food & beverage$10,23813%
- Education$12,76817%
- Other$12,50016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 141 | $53,962 |
| Intuitive Surgical | 10 | $12,740 |
| Axonics, Inc. | 126 | $4,103 |
| Caldera Medical, Inc | 11 | $2,225 |
| Medtronic(2 entities) | 31 | $932 |
| Seaspine Orthopedics Corporation | 3 | $807 |
| Boston Scientific | 14 | $776 |
| AbbVie(2 entities) | 23 | $318 |
| Momentis Surgical Inc. | 1 | $183 |
| Pfizer | 10 | $132 |
| Astellas Pharma US Inc | 9 | $127 |
| Therapeuticsmd, Inc. | 7 | $95 |
| Sumitomo Pharma America, Inc. | 6 | $87 |
| AMAG Pharmaceuticals, Inc. | 6 | $81 |
| Bluewind Medical | 2 | $65 |
| Avanos Medical | 2 | $45 |
| Contura, Inc. | 1 | $30 |
| Biocompatibles, Inc. | 1 | $16 |
| Millicent US Inc | 1 | $15 |
| Mission Pharmacal Company | 1 | $15 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $15 |
| Mycovia Pharmaceuticals, Inc. | 1 | $13 |
| Urovant Sciences Inc | 1 | $12 |
| Escala Medical Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$42,621
- DAVINCI XI$12,500
- Saffron$6,510
- Axonics$2,089
- Desara$2,015
- Bulkamid$1,984
- Vertessa$1,745
- Vu aPOD Prime NanoMetalene$796
- Cabo$796
- Mariner$796
- Skipjack$796
- AXIS$517
- Regatta$407
- TITAN$328
- RESTORELLE$283
- INTERSTIM$260
- Anovo Surgical System$183
- Solyx SIS System$167
- EndoFlip$123
- UPSYLON$108
How this compares
$76,802 in reported general payments places this provider in the 95th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.
See all urogynecology and reconstructive pelvic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 118 | $84,745 |
| GemtesaVibegron | 111 | $78,713 |
| Mirabegron ErMirabegron | 16 | $5,985 |
| Estradiol | 76 | $5,190 |
| Methenamine Hippurate | 33 | $3,008 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 75 | $751 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $326 |
| Ibuprofen | 30 | $87 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $85 |
| Tramadol Hcl | 19 | $40 |
| Ciprofloxacin Hcl | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $127 | $84,745118 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $87 | $78,713111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 35 urogynecology and reconstructive pelvic surgery providers in New Jersey.
Other urogynecology and reconstructive pelvic surgery in Manalapan
- Debra FromerHackensack$50K
- Donald DebrakeleerPennington$36K
- Uzma ChaudhryTrenton$14K
- Alexander BergerCherry Hill$14K
- Kristene WhitmoreCherry Hill$13K
- Betsy GreenleafHowell$11K
- Sandy NosseirMarlton$11K
- Gary MironeCape May Court House$9K
- Anna PancheshnikovVoorhees$8K
- Patricia ZahnerMoorestown$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.